Azobenzenes
Medchemexpress LLC WR99210 50mg | 47326-86-3 | 394.7 g/mol | C14H18Cl3N5O2 | 50 MG
WR99210 is a potent dihydrofolate reductase (DHFR) inhibitor used in antiparasitic research and as a selection reagent for Plasmodium transfection. It is supplied as a research-grade free base and is used in laboratory studies that require selective inhibition of parasite DHFR.
- Potent dihydrofolate reductase (DHFR) inhibition with subnanomolar activity.
- Commonly used as a selection reagent for Plasmodium transfection experiments.
- Provided as the free base form suitable for research applications.
- Typical pack size: 50 mg.
- For research use only; not for human or clinical use.
![eMolecules Ambeed / (S)-2-(Benzo[b]thiophen-2-yl)-4-benzyl-45-dihydrooxazole / 50mg / 665578597 / A1493991 / / 2170033-85-7 / [null] / 293.380 / C18H15NOS](https://assets.fishersci.com/TFS-Assets/CCG/product-images/502452393.PNG-250.jpg)
eMolecules Ambeed / (S)-2-(Benzo[b]thiophen-2-yl)-4-benzyl-45-dihydrooxazole / 50mg / 665578597 / A1493991 / / 2170033-85-7 / [null] / 293.380 / C18H15NOS
Ambeed / (S)-2-(Benzo[b]thiophen-2-yl)-4-benzyl-45-dihydrooxazole / 50mg / 665578597 / A1493991 / / 2170033-85-7 / [null] / 293.380 / C18H15NOS
Medchemexpress LLC FzM1.8 50mg | 2204290-85-5 | 322.31 g/mol | C18H14N2O4 | 50 MG
FzM1.8 is a small-molecule allosteric agonist of the Frizzled receptor FZD4 that activates the WNT/β-catenin signaling pathway by promoting TCF/LEF transcriptional activity in the absence of WNT ligand. The compound is provided as a research-grade, purified material with reported physicochemical and handling data suitable for in vitro and in vivo studies.
- Allosteric agonist of FZD4 that activates the WNT/β-catenin pathway.
- Suitable for in vitro and in vivo research applications.
- High reported purity (98.93%) for reproducible results.
- Molecular formula C18H14N2O4 and molecular weight 322.31 g/mol.
- Soluble in DMSO (≈83.33 mg/mL) and formulatable for in vivo dosing.
- Recommended storage: powder -20°C (3 years) or 4°C (2 years); in solvent -80°C (2 years).
Chemscene ChemScene | 4-Bromo-1,8-naphthalic anhydride | 100G | CS-0015910 | 0.97 | 81-86-7| MFCD00006927 | 277.073
ChemScene | 4-Bromo-1,8-naphthalic anhydride | 100G | CS-0015910 | 0.97 | 81-86-7| MFCD00006927 | 277.073
![eMolecules Ambeed / Thieno[32-b]thiophene-2-carbaldehyde / 1g / 525077647 / A162309 / / 31486-86-9 / MFCD01859924 / 168.230 / C7H4OS2](https://assets.fishersci.com/TFS-Assets/CCG/product-images/502453987.PNG-250.jpg)
eMolecules Ambeed / Thieno[32-b]thiophene-2-carbaldehyde / 1g / 525077647 / A162309 / / 31486-86-9 / MFCD01859924 / 168.230 / C7H4OS2
Ambeed / Thieno[32-b]thiophene-2-carbaldehyde / 1g / 525077647 / A162309 / / 31486-86-9 / MFCD01859924 / 168.230 / C7H4OS2
Medchemexpress LLC D5D-IN-326 | 1236767-85-3 | 99.9% | 473.27 | C17H11F8N3O4 | 10 MG
D5D-IN-326 is a selective, orally active delta-5 desaturase (D5D) inhibitor used in preclinical research. It demonstrates low-nanomolar potency in enzymatic and cell-based assays and has been reported to improve metabolic parameters in diet-induced obese mice. Documentation typically includes a product datasheet, certificate of analysis, and safety data sheet.
- Selective delta-5 desaturase inhibition with low-nanomolar potency.
- Demonstrated activity in enzymatic and cell-based assays.
- Reduces insulin resistance and body weight in preclinical mouse models.
- High purity (99.9% by LC-MS) confirmed by certificate of analysis.
- Supplied as a small-molecule research reagent with supporting documentation for reproducibility.
eMolecules Medchem Express / ML349 / 5mg / 446255990 / HY-100737 / / 890819-86-0 / MFCD14808090 / 454.560 / C23H22N2O4S2
Medchem Express / ML349 / 5mg / 446255990 / HY-100737 / / 890819-86-0 / MFCD14808090 / 454.560 / C23H22N2O4S2
Medchemexpress LLC Cadrofloxacin 10mg | 153808-85-6 | 411.38 g·mol^-1 | C19H20F3N3O4 | 10 MG
Cadrofloxacin is a fluoroquinolone antibiotic research compound supplied as a white to off-white solid for laboratory use. It is intended for antibacterial and anti-infection research and is provided with supporting documentation for safe handling and characterization.
- Fluoroquinolone antibiotic used for antibacterial research.
- High purity suitable for analytical and experimental work.
- White to off-white solid powder, convenient for dissolution or formulation.
- Stable when stored frozen as recommended for long-term storage.
- Available with data sheet, certificate of analysis, and safety data sheet.
Medchemexpress LLC FzM1.8 | 322.3 g/mol | C18H14N2O4 | 10MG
FzM1 8 derives from FzM1 is an allosteric agonist of FZD4 with pEC50 of 6 4 FzM1 8 binds to FZD4 and activates the WNT/ -catenin pathway by promoting TCF/LEF transcriptional activity in the absence of any WNT ligand FzM1 8 stabilizes FZD4 with an increased affinity for heterotrimeric G protein and stimulates the release of the G subunit that in turn activates PI3K[1]
eMolecules Medchem Express / WWL113 / 5mg / 713704307 / HY-110148 / / 947669-86-5 / MFCD28160857 / 466.537 / C29H26N2O4
Medchem Express / WWL113 / 5mg / 713704307 / HY-110148 / / 947669-86-5 / MFCD28160857 / 466.537 / C29H26N2O4
eMolecules Ambeed / 23-Dimethoxyterephthalaldehyde / 100mg / 599119640 / A532477 / / 179693-85-7 / MFCD18072900 / 194.186 / C10H10O4
Ambeed / 23-Dimethoxyterephthalaldehyde / 100mg / 599119640 / A532477 / / 179693-85-7 / MFCD18072900 / 194.186 / C10H10O4
Medchemexpress LLC 4-hydroxy-2-methyl-1,1-dioxo-N-(1,3-thiazol-2-yl)-1λ6,2-benzothiazine-3-carboxamide | 34042-85-8 | MFCD00866053 | 100.0% | 337.37 g/mol | C13H11N3O4S2 | 100 MG
Sudoxicam is an enol-carboxamide non-steroidal anti-inflammatory compound that functions as a reversible cyclooxygenase (COX) antagonist. It is provided as a high-purity analytical reagent intended for in-vitro and preclinical research use only (not for human or clinical use).
- Purity: 99.96%.
- CAS number: 34042-85-8.
- Molecular weight: 337.37 g/mol.
- Molecular formula: C13H11N3O4S2.
- Typical pack size: 100 mg solid.
- Intended use: research reagent and analytical standard for COX inhibition studies.